Extracellular Vesicles (EVs) are a growing segment of Regenerative Medicine and are particularly attractive as a therapeutic model utilizing a non-viable biologically active agent. In her presentation at ISEV, Taby Ahsan will discuss considerations for manufacturing of EVs derived from mesenchymal stem or stromal cells, including the tissue source, the cell state, and process parameters. She will also discuss the importance of evaluating EV productivity in manufacturing processes, highlighting limitations and advantages of 2D and 3D bioreactor production.

Presented by Taby Ahsan, PhD
ISEV 2020 Virtual conference